Merck announces new biopharma heads for North America and China Merck announces new biopharma heads for North America and China Gary Zieziula and Marc Horn to head biopharma business in North America and China, respectively Adam Ryan Goodsell joins Business Development Team at Laurus Synthesis Adam Ryan Goodsell joins Business Development Team at Laurus Synthesis Will build sales in the Boston Biotech community Avacta hires Philippe Cotrel as Chief Commercial Officer Avacta hires Philippe Cotrel as Chief Commercial Officer Joins the UK firm from Abcam Averica Discovery appoints Cynthia Berger as Vice President of Operations Averica Discovery appoints Cynthia Berger as Vice President of Operations Will contribute broadly to the firm's growth and development Professor Graham Boulnois to become Chairman of the Medicines Technologies Catapult Professor Graham Boulnois to become Chairman of the Medicines Technologies Catapult The new Medicines Technologies Catapult at Alderley Park, Cheshire, UK, will support industry in developing new technologies primarily for the preclinical evaluation of medicines Recipharm appoints new Key Account Director for Europe Recipharm appoints new Key Account Director for Europe Anke Mollowitz is responsible for coordinating customer management and commercial aspects Remi Palmantier becomes Chief Scientific Officer at Genticel Remi Palmantier becomes Chief Scientific Officer at Genticel Will accelerate the discovery, development and integration of specific immunotherapies Chief Medical Officer Birgitte Volck to leave Sobi Chief Medical Officer Birgitte Volck to leave Sobi To join GlaxoSmithKline as Head of R&D Rare Diseases Ergomed makes changes to Board of Directors Ergomed makes changes to Board of Directors Neil Clark becomes CEO of PrimeVigilance, while Stephen Stamp is appointed as Chief Financial Officer of Ergomed Crown Bioscience hires Global Scientific Director for Translational Oncology Crown Bioscience hires Global Scientific Director for Translational Oncology Eric Murphy has focused on translational and drug discovery research for more than two decades ClinTec International expands executive leadership team ClinTec International expands executive leadership team Hires Dr Harley Simon as Chief Medical Officer & Executive Vice President Client Relations West appoints VP, Corporate Development, Strategy and Investor Relations West appoints VP, Corporate Development, Strategy and Investor Relations Quintin Lai joins the US firm from Sigma Aldrich Chalcroft announces new structure following significant growth Chalcroft announces new structure following significant growth Gives new roles to management and makes some promotions Frank Mathias to become CEO of Rentschler Biotechnologie Frank Mathias to become CEO of Rentschler Biotechnologie Nikolaus Rentschler joins supervisory board to concentrate on further expansion of the Rentschler Group Recipharm appoints General Manager for its new blow fill seal subsidiary in Kaysersberg, France Recipharm appoints General Manager for its new blow fill seal subsidiary in Kaysersberg, France Yves Buelens, who has been plant manager since 2014, gains a promotion Ardelyx appoints Paul Korner as Executive Vice President and Chief Medical Officer Ardelyx appoints Paul Korner as Executive Vice President and Chief Medical Officer He beings extensive experience to the newly created role HUYA Bioscience International expands senior management team HUYA Bioscience International expands senior management team Recruits Dmitri Kharkevitch as Vice President for Clinical Development Lars Dreiøe to join Sobi as Senior Vice President, Chief Quality & Compliance Officer Lars Dreiøe to join Sobi as Senior Vice President, Chief Quality & Compliance Officer Brings two decades of experience in quality, manufacturing, product safety and regulatory affairs to the firm Catalent Biologics hires Kevin Hambly as Vice President, Business Development and Licensing Catalent Biologics hires Kevin Hambly as Vice President, Business Development and Licensing Will lead business activity concerning SMARTag bioconjugation technology Lonza announces change to Executive Committee Lonza announces change to Executive Committee Sven Abend, Chief Strategy Officer and member of the Executive Committee, takes responsibility for Specialty Ingredients from Beat In-Albon Immune Pharmaceuticals appoints John Mohr as Senior Vice President of Business Development Immune Pharmaceuticals appoints John Mohr as Senior Vice President of Business Development New role strengthens Immune's ability to advance portfolio through strategic partnering Joseph P. Hagan becomes Chief Operating Officer at Regulus Joseph P. Hagan becomes Chief Operating Officer at Regulus He brings nearly 15 years of experience to the La Jolla, CA, US-based firm Belgian biotech Promethera makes two senior appointments Belgian biotech Promethera makes two senior appointments Dr Jürgen Beck is hired as VP Clinical and Medical Affairs, with Patrick Stragier as VP Operations Schott researcher receives Turner Award Schott researcher receives Turner Award Professor Volker Rupertus is honoured for his involvement in the International Commission on Glass